About: Monomethyl fumarate     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : dbo:Drug, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon
http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FMonomethyl_fumarate&invfp=IFP_OFF&sas=SAME_AS_OFF

Monomethyl fumarate, sold under the brand name Bafiertam is a medication for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is taken by mouth. The most common adverse reactions are flushing, abdominal pain, diarrhea, and nausea. It was approved for medical use in the United States in April 2020.

AttributesValues
rdf:type
rdfs:label
  • Monomethyl fumarate (en)
rdfs:comment
  • Monomethyl fumarate, sold under the brand name Bafiertam is a medication for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is taken by mouth. The most common adverse reactions are flushing, abdominal pain, diarrhea, and nausea. It was approved for medical use in the United States in April 2020. (en)
foaf:depiction
  • http://commons.wikimedia.org/wiki/Special:FilePath/Monomethyl_fumarate_skeletal.svg
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
dbp:wikiPageUsesTemplate
thumbnail
ATC prefix
  • None (en)
c
CAS number
ChEBI
ChEMBL
ChemSpiderID
DrugBank
  • DB14219 (en)
H
IUPAC name
KEGG
  • D11492 (en)
legal US
  • Rx-only (en)
O
PubChem
routes of administration
SMILES
  • COCC=CCO (en)
StdInChI
StdInChIKey
  • NKHAVTQWNUWKEO-NSCUHMNNSA-N (en)
tradename
  • Bafiertam (en)
UNII
has abstract
  • Monomethyl fumarate, sold under the brand name Bafiertam is a medication for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is taken by mouth. The most common adverse reactions are flushing, abdominal pain, diarrhea, and nausea. It was approved for medical use in the United States in April 2020. (en)
DailyMedID
  • Monomethyl_fumarate (en)
prov:wasDerivedFrom
page length (characters) of wiki page
alternative name
  • Bafiertam (en)
CAS number
  • 2756-87-8
ChEBI
  • 167450
ChEMBL
  • 589586
DrugBank
  • DB14219
FDA UNII code
  • 45IUB1PX8R
KEGG
  • D11492
PubChem
  • 5369209
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is Wikipage redirect of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 56 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software